Literature DB >> 24590640

Genetic biomarkers for Fluorouracil toxicity prediction: the long road to clinical utility.

Adam M Lee1, Robert B Diasio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24590640     DOI: 10.1200/JCO.2013.53.4479

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Genotype-phenotype correlations in 5-fluorouracil metabolism: a candidate DPYD haplotype to improve toxicity prediction.

Authors:  G Gentile; A Botticelli; L Lionetto; F Mazzuca; M Simmaco; P Marchetti; M Borro
Journal:  Pharmacogenomics J       Date:  2015-07-28       Impact factor: 3.550

2.  Pre-treatment evaluation of 5-fluorouracil degradation rate: association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort.

Authors:  Federica Mazzuca; Marina Borro; Andrea Botticelli; Eva Mazzotti; Luca Marchetti; Giovanna Gentile; Marco La Torre; Luana Lionetto; Maurizio Simmaco; Paolo Marchetti
Journal:  Oncotarget       Date:  2016-04-12

3.  Pancytopenia and Severe Gastrointestinal Toxicities Associated with 5-Fluorouracil in a Patient with Thymidylate Synthase (TYMS) Polymorphism.

Authors:  Bo Wang; Shannon J Walsh; Muhammad W Saif
Journal:  Cureus       Date:  2016-09-21

4.  Exome array analysis of adverse reactions to fluoropyrimidine-based therapy for gastrointestinal cancer.

Authors:  Matthew Traylor; Jemma L Walker; Adele A Corrigan; Monica A Hernandez; Stephen J Newhouse; Amos A Folarin; Hamel Patel; Paul J Ross; Jeremy D Sanderson; James Spicer; Natalie J Prescott; Christopher G Mathew; Anthony M Marinaki; Cathryn M Lewis
Journal:  PLoS One       Date:  2018-05-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.